← All science articles

· 2 min read

PDRN Ovules Tested After Cervical Laser and Cauterization Procedures

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

This 1990 study, published in Annali di ostetricia, ginecologia, medicina perinatale by Perino and colleagues, examined whether polydeoxyribonucleotide (PDRN) might support the cervix's recovery after two standard procedures for benign cervical lesions: laser vaporization and cauterization. PDRN, a compound made of short DNA fragments, was given as a 5 mg vaginal ovule, sold under the name POLIDES 5, which the authors describe as having re-epithelialization and anti-complement properties — meaning it was thought to support new surface tissue growth and dampen part of the immune inflammatory response.

The trial enrolled 91 patients in two groups. Group A had 45 patients treated with laser vaporization, 23 given PDRN ovules and 22 given placebo. Group B had 46 patients treated with cauterization, 24 given PDRN and 22 given placebo. Treatment started the day of the procedure and ran for twelve days. Patients were assessed beforehand and again at a 14-day follow-up using Pap smears, colposcopy (visual cervical examination), and microcolpohysteroscopy, a method for mapping the surface in detail.

The available abstract is truncated and stops before reporting the actual comparative results between the PDRN and placebo groups. As a human trial it describes a real clinical design, but without the numerical outcomes, no conclusion about PDRN's effect can be drawn from this record alone.

Our reflection

This trial shows PDRN being studied directly in people, in a gynecological rather than cosmetic setting, decades before today's interest in skin and tissue applications. Even with its results unavailable here, it illustrates how broadly researchers explored this compound class. At Havdis, we see such studies as part of the long research history that today's PDRN work builds on.

Source

Perino A, Genova G, Vita C, Costa P, Biondo A, Palmeri MA et al. (1990). Annali di ostetricia, ginecologia, medicina perinatale.

Read the paper on PubMed

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.